EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Targeting catalase in cancer

Christophe Glorieux, Pedro Buc Calderon

Redox Biology · 2024-11 · 77 · 103404

DOI: 10.1016/j.redox.2024.103404 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Redox Biology, 2024-11. Verfasst von Christophe Glorieux und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 510060, G…. Hauptthemen laut MEDLINE: Catalase, Neoplasms, Oxidative Stress, Reactive Oxygen Species. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondo Nacional de Ciencia y Tecnología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Healthy cells have developed a sophisticated network of antioxidant molecules to prevent the toxic accumulation of reactive oxygen species (ROS) generated by diverse environmental stresses. On the opposite, cancer cells often exhibit high levels of ROS and an altered levels of antioxidant molecules compared to normal cells. Among them, the antioxidant enzyme catalase plays an essential role in cell defense against oxidative stress through the dismutation of hydrogen peroxide into water and molecular oxygen, and its expression is often decreased in cancer cells. The elevation of ROS in cancer cells provides them proliferative advantages, and leads to metabolic reprogramming, immune escape and metastasis. In this context, catalase is of critical importance to control these cellular processes in cancer through various mechanisms. In this review, we will discuss the major progresses and challenges in understanding the role of catalase in cancer for this last decade. This review also aims to provide important updates regarding the regulation of catalase expression, subcellular localization and discuss about the potential role of microbial catalases in tumor environment. Finally, we will describe the different catalase-based therapies and address the advantages, disadvantages, and limitations associated with modulating catalase therapeutically in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatalaseNeoplasmsOxidative StressReactive Oxygen SpeciesHumansAnimalsAntioxidantsGene Expression Regulation, NeoplasticMolecular Targeted Therapy

Stichwörter der Autor:innen

CancerCatalaseCatalase-based therapyRegulationSubcellular localizationTumor environment

Substanzen

CatalaseReactive Oxygen SpeciesAntioxidants

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 510060, Guangzhou, China. Electronic address: christophe@sysucc.org.cn.
  • Química y Farmacia, Facultad de Ciencias de La Salud, Universidad Arturo Prat, 1100000, Iquique, Chile; Instituto de Química Medicinal, Universidad Arturo Prat, 1100000, Iquique, Chile; Research Group in Metabolism and…

Förderung

  • Fondo Nacional de Ciencia y Tecnología

Zitieren

APA

Glorieux, C., & Buc Calderon, P. (2024). Targeting catalase in cancer. Redox Biology, 77, 103404. https://doi.org/10.1016/j.redox.2024.103404

Vancouver

Glorieux C, Buc Calderon P. Targeting catalase in cancer. Redox Biology. 2024;77:103404. doi:10.1016/j.redox.2024.103404

BibTeX
@article{Glorieux2024,
  author = {Glorieux, Christophe and Buc Calderon, Pedro},
  title = {Targeting catalase in cancer},
  journal = {Redox Biology},
  year = {2024},
  volume = {77},
  pages = {103404},
  doi = {10.1016/j.redox.2024.103404}
}
Kostenlos starten →